When was the Company founded?
The Company was founded in June 2016.
How can I buy and sell shares?
Cannpal’s shares are traded on the ASX and can be bought or sold through a Licensed Stock Broker. The process of buying or selling shares is explained on the ASX website.
Where can I view the Company prospectus?
You can view the Cannpal prospectus here.
What is the Company’s ASX code?
The Company’s ASX code is CP1
Where can I find information about my Shareholdings?
The CannPal share register is managed by Computershare Investor Services Pty Ltd (Computershare). Computershare provides a number of services which can be accessed online. When accessing some information online you may be required to enter your Security Reference Number (SRN) or Holder Identification Number (HIN) as shown on your Issuer Sponsored/CHESS statements and other personal details such as your postcode.
Please contact Computershare if you have any inquiries. It will assist if you can quote your current address together with your Security Reference Number (SRN) or Holder Identification Number (HIN) as shown on your Issuer Sponsored/CHESS statements.
Computershare Investor Services Pty Ltd
1300 367 027
International(+61 3) 9946 4421
Postal address
The Registrar Computershare Investor Services Pty Ltd
GPO Box 2975
Office address
Level 11, 172 St George’s Terrace
Who can I contact about media inquiries?
Media enquiries
Julia Maguire
The Capital Network
M+61 419 815 386
Is Cannabis legal for animals?
The regulatory environment around cannabis for animals is still very unclear. In all major jurisdictions that we are aware of, medical cannabis for animals is illegal, unless it’s being used for medical research purposes and with the necessary permits.
How can I treat my animal with medical cannabis?
You should always seek professional advice from a veterinarian when treating animals for any illness. Unfortunately we cannot give you advice, but we are working towards having our products scientifically tested, validated and labelled correctly to inform and allow veterinarians to prescribe medical cannabis medications for animals.
When can I buy your products?

CannPal is working with regulatory authorities to validate the safety and efficacy of medical cannabis for use in companion pets. This is an arduous process and involves robust clinical studies that take time. This process in its entirety can take 3 to 4 years and in some cases more.
However medical cannabis is an evolving industry and while we will continue to complete the required safety and efficacy studies to show our products are safe and efficacious for regulatory authorities, we are following the legislative changes closely and should there be an opportunity to enter a legal market earlier than anticipated, we are well placed to do so.
We are also researching the benefits of CBD derived from hemp, which isn’t bound by the same legislative rules as medical cannabis. We hope to be able to market a product derived from the hemp plant as early 2019.
Is cannabis dangerous for pets?

Cannabis can be dangerous for animals when taken incorrectly. Dogs have more cannabinoid receptors than humans and can be very sensitive to THC, the psychoactive cannabinoid in cannabis. If you suspect your dog has consumed marijuana without your supervision, take them to the vet immediately. The following signs indicate that your dog may have consumer too much cannabis:
Dribbling urine
Walking like they’re intoxicated
Beginning to fall over while standing still
Low heart rate
Low blood pressure
Wide, dilated pupils
Easily startled by sudden sounds
However when consumed in the correct ratios of cannabinoids and dosages, and under medical supervision, cannabis is a wonderful medicine for a range of ailments and we’re working to be able to provide pet owners with safe, standardised and dosage controlled medicines using cannabis.
Where can I view the Company’s corporate governance plan?
You can view all the Company’s policies and the corporate governance plan here
Where are you up to with you research?
You can follow our research progress in the Research and Development section of our website. Click here to go there now.